Terminal Access

Unlimited access to the most powerful analytical tools in finance.

Bloomberg Fair Value
20M Securities
50Y History
10Y Estimates
8.000+ News Daily
Subscribe for $2
Overview
Profile

Medifast stock

MED
US58470H1014
889384

Price

12.20
Today +/-
+0.04
Today %
+0.33 %

Medifast stock price

%
Weekly
Details

Price

ⓘ

Overview

The Quote Chart provides detailed and dynamic insights into the Medifast stock's performance, showcasing daily, weekly, or monthly aggregated quotes. Users can switch between different time frames to analyze the stock's progression meticulously and make informed investment decisions.

Intraday Feature

The intraday feature provides real-time data, allowing investors to view the Medifast stock’s price fluctuations within the trading day, facilitating timely and strategic investment decisions.

Total Return and Relative Price Change

View the total return of the Medifast stock to gauge its profitability over time. The relative price change, based on the first quote available in the selected timeframe, offers insights into the stock’s performance, assisting in evaluating its investment potential.

Interpretation and Investment

Utilize the comprehensive data presented in the Quote Chart to analyze Medifast's market trends, price movements, and potential returns. Make informed investment choices by comparing different time frames and evaluating intraday data for optimized portfolio management.

Medifast Stock Price History

DateMedifast Price
4/25/202512.20 undefined
4/24/202512.16 undefined
4/23/202512.03 undefined
4/22/202512.20 undefined
4/21/202511.86 undefined
4/17/202511.93 undefined
4/16/202512.04 undefined
4/15/202512.51 undefined
4/14/202512.93 undefined
4/11/202512.73 undefined
4/10/202513.19 undefined
4/9/202512.90 undefined
4/8/202512.59 undefined
4/7/202512.97 undefined
4/4/202513.21 undefined
4/3/202513.04 undefined
4/2/202513.68 undefined
4/1/202512.99 undefined
3/31/202513.50 undefined
3/28/202513.85 undefined

Medifast Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into Medifast, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Medifast from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Medifast’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Medifast. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Medifast’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Medifast’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Medifast’s growth potential.

Medifast Revenue, EBIT and net profit per share

DateMedifast RevenueMedifast EBITMedifast Net Income
2026e398.04 M undefined-10.61 M undefined-16.46 M undefined
2025e410.16 M undefined-10.1 M undefined-11.6 M undefined
2024602.46 M undefined19.47 M undefined2.09 M undefined
20231.07 B undefined126.4 M undefined99.42 M undefined
20221.6 B undefined184.8 M undefined143.6 M undefined
20211.53 B undefined216.2 M undefined164 M undefined
2020934.8 M undefined141.2 M undefined102.9 M undefined
2019713.7 M undefined91 M undefined77.9 M undefined
2018501 M undefined69.1 M undefined55.8 M undefined
2017301.6 M undefined39.6 M undefined27.7 M undefined
2016274.5 M undefined26.9 M undefined17.8 M undefined
2015272.8 M undefined28.7 M undefined20.1 M undefined
2014285.3 M undefined30.2 M undefined13.2 M undefined
2013324.1 M undefined38.4 M undefined24 M undefined
2012318.6 M undefined27.1 M undefined15.9 M undefined
2011298.2 M undefined27.4 M undefined18.5 M undefined
2010257.6 M undefined31.6 M undefined19.6 M undefined
2009169.7 M undefined18.5 M undefined11.4 M undefined
2008110.1 M undefined7.4 M undefined4.3 M undefined
200783.8 M undefined5.7 M undefined3.4 M undefined
200674.1 M undefined7.4 M undefined5.2 M undefined
200540.1 M undefined3.5 M undefined2.1 M undefined

Medifast Income Statement, Balance Sheet, Cash Flow Statement

  • Simple

  • Expanded

  • Income Statement

  • Balance Sheet

  • Cashflow

 
REVENUE (B)
REVENUE GROWTH (%)
GROSS MARGIN (%)
GROSS INCOME (B)
NET INCOME (M)
NET INCOME GROWTH (%)
DIV. ()
DIV. GROWTH (%)
SHARES (M)
DOCUMENTS
19941995199619971998199920002001200220032004200520062007200820092010201120122013201420152016201720182019202020212022202320242025e2026e
0.010.020.020.010.01000.010.010.030.030.040.070.080.110.170.260.30.320.320.290.270.270.30.50.710.931.531.61.070.60.410.4
-77.78--12.50-57.14-33.33-25.0066.67140.00108.338.0048.1585.0012.1632.5353.6452.0715.956.711.89-12.04-4.560.749.8566.4542.3231.0063.384.72-32.92-43.84-31.89-2.93
33.3337.5043.7528.5750.0050.0066.6740.0066.6772.0074.0775.0074.3274.7071.8273.3774.7175.1773.9074.0773.3373.9074.8275.4275.6575.1874.6373.8571.3472.2973.75108.29111.56
00.010.01000000.010.020.020.030.060.060.080.120.190.220.240.240.210.20.210.230.380.540.71.131.140.780.4400
000-3-1-31022125341119181524132017275577102164143992-11-16
-----66.67200.00-133.33----50.00100.00150.00-40.0033.33175.0072.73-5.26-16.6760.00-45.8353.85-15.0058.82103.7040.0032.4760.78-12.80-30.77-97.98-650.0045.45
---------------------------------
---------------------------------
44.24.54.34.85.55.68.18.71112.412.813.513.614.314.714.614.213.713.812.812.111.912.112.112.111.911.811.310.9210.9600
---------------------------------
Details

Keystats

ⓘ

Revenue and Growth

The Medifast Revenue and Revenue Growth are pivotal to understanding the company's financial health and operational efficiency. A consistent increase in revenue indicates a company’s ability to effectively market and sell its products or services, while the revenue growth percentage offers insights into the pace at which the company is expanding over the years.

Gross Margin

The Gross Margin is a crucial metric that showcases the percentage of revenue exceeding the cost of goods sold (COGS). A higher gross margin is indicative of a company’s efficiency in controlling its production costs, thereby promising potential profitability and financial stability.

EBIT and EBIT Margin

EBIT (Earnings Before Interest and Taxes) and EBIT Margin offer deep insights into a company’s profitability, excluding the impacts of interest and taxes. Investors often assess these metrics to gauge the operational efficiency and inherent profitability of a business, separate from its financial structure and tax environment.

Income and Growth

Net Income and its subsequent growth are quintessential for investors looking to understand a company’s profitability. Consistent income growth underscores a company’s ability to enhance its profitability over time, reflecting operational efficiency, strategic competitiveness, and financial health.

Shares Outstanding

Shares outstanding refer to the total number of shares a company has issued. It's instrumental in calculating key metrics like Earnings Per Share (EPS) which is pivotal for investors to evaluate a company’s profitability on a per-share basis, offering a more granular view of financial health and valuation.

Interpreting Year to Year Comparison

Comparing yearly data allows investors to identify trends, assess the company’s growth, and anticipate potential future performance. Analyzing how metrics like revenue, income, and margins change year over year can provide valuable insights into the company’s operational efficiency, competitiveness, and overall financial health.

Expectations and Predictions

Investors often juxtapose the current and past financial data with the market’s expectations. This comparison aids in assessing whether the Medifast is performing as anticipated, underperforming or outperforming the market predictions, providing pivotal data for investment decisions.

 
ASSETS
CASH BALANCE (M)
RECEIVABLES (M)
OTHER REC. (M)
INVENTORIES (M)
OTHER CURRENT LIAB. (M)
CURRENT ASSETS (M)
TANGIBLE ASSETS (M)
LONG-T. INVEST. (M)
LONG-T. REC. (M)
INTANGIBLE ASSETS (M)
GOODWILL (k)
OTHER NON-CURRENT ASSETS (M)
NON-CURRENT ASSETS (M)
TOTAL ASSETS (M)
LIABILITIES
COMMON STOCK (M)
ADDITIONAL PAID-IN CAPITAL (M)
RETAINED EARNINGS (M)
OTHER EQUITY (k)
UNREAL. GAINS/LOSSES (k)
EQUITY (M)
LIABILITIES (M)
PROVISIONS (M)
OTHER SHORT-TERM LIAB. (M)
SHORT-TERM DEBTS (M)
LONG-TERM DEBT PORTION (M)
SHORT-TERM REC. (M)
LONG-T. LIAB. (M)
DEFERRED TAXES (M)
OTHER LIAB. (M)
LONG-T. LIABILITIES (M)
DEBT (M)
TOTAL CAPITAL (M)
199519961997199819992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024
                                                           
0.30.30.30.50.20.30.61.36.53.24.22.63.62.916.334.433.86067.852.667.176.898.810192.7174.5109.587.7150.04162.34
0.91.61.13.30.30.30.30.30.61.110.40.50.40.70.61.52.10.91.71.61.40.611.40.60000
000000000000.20.21.42.93.35.40.9051.61.22.205.200000
3.13.92.42.70.50.60.61.334.35.58.39.213.911.219.52020.817.515.713.318.319.338.948.853.4180118.954.5942.42
0.40.50.30.400.30.51.31.81.43.83.43.62.94.52.83.44.85.66.83.33.54.24.66.15.916.316.210.679.64
4.76.34.16.911.524.211.91014.514.917.121.535.660.664.188.691.881.886.9101.2125.1145.5154.2234.4305.8222.8215.3214.4
3.93.62.73.310.90.84.57.48.79.5141721.723.230.638.940.134.533.52919.818.619.738.838.180.675.667.1148.68
000000000000000000000000000000
000000000001.41.21.10000000000000000
0.10.1000000.63.96.25.15.97.45.51.41.110.4000000000000
5005000000009009009000000000000000000000
0.210.20.10.10.80.70.700.20.20.610.52.71.71.81.16.20.50.20.22.14.21.73.610.917.818.7721.13
4.75.22.93.41.11.71.55.812.21615.721.926.628.827.333.441.741.640.73429.22020.723.940.541.791.593.485.8869.81
9.411.5710.32.13.23.51024.12630.236.843.750.362.994105.8130.2132.5115.8116.1121.2145.8169.4194.7276.1397.3316.2301.18284.21
                                                           
00.70.80.70.61.21.51.50.70.50000000000000000000.010.01
6.76.97.18.38.698.99.620.120.621.826.62725.328.532.936.140.201.102.758.807.81221.626.5733.14
-1.7-1.4-5.1-6.1-9.4-8.3-7.8-5.4-3-1.30.869.812.322.542.160.776.597.778.988.693.5103.8131.3168.8154.4190.3139.9174.65176.78
0000000000200-3,000-2,400-400200200400600700400-100-200-2000001000-48-1
00000000000000000000000-200010000296181
56.22.82.9-0.21.92.65.717.819.822.829.634.437.251.275.297.2117.398.480.488.596108.6139.9168.8162.3202.4161.5201.48210.11
1.81.811.80.70.20.10.310.31.72.23.23.74.29.312.728.21212.211.39.616.121.822.635.870.958.747.9623.05
00.40.60.90.20.20.20.70.60.60.60.71.11.53.55.76.2010.29.78.210.714.929.438.754.173.754.842.3638.66
00000000.20.20.710.50.60.400004.64.93.94.26.19.118.121.425.227.41.982.45
00000.40.300.10.10.40.61.31.63.20000000000000000
0.42.10.30.70.50.10.10.30.80.50.60.50.30.30.80.91.40.50.20.20.2000000000
2.24.31.93.41.80.80.41.62.72.54.55.26.89.18.515.920.328.7272723.624.537.160.379.4111.3169.8140.992.364.16
2.30.92.24.10.50.60.22.74.64.343.54.64.35.44.94.33.80.50.20000000000
00000000000001.91.21.37.86.96.75.53.70.80.20000000
00000000000000000002.80.300010.47.52620.316.139.94
2.30.92.24.10.50.60.22.74.64.343.54.66.26.66.212.110.77.28.540.80.2010.47.52620.316.139.94
4.55.24.17.52.31.40.64.37.36.88.58.711.415.315.122.132.439.434.235.527.625.337.360.389.8118.8195.8161.2108.4374.1
9.511.46.910.42.13.33.21025.126.631.338.345.852.566.397.3129.6156.7132.6115.9116.1121.3145.9200.2258.6281.1398.2322.7309.91284.21
Details

Balance Sheet

ⓘ

Understanding the Balance Sheet

The balance sheet of Medifast provides a detailed financial snapshot, revealing the company's assets, liabilities, and equity at a specific point in time. Analyzing these components is crucial for investors looking to understand Medifast's financial health and stability.

Assets

Medifast's assets represent everything the company owns or controls that has monetary value. These are categorized into current and non-current assets, offering insights into the company's liquidity and long-term investments.

Liabilities

Liabilities are obligations that Medifast must settle in the future. Analyzing the ratio of liabilities to assets provides insights into the company's financial leverage and risk exposure.

Equity

Equity refers to the residual interest in the assets of Medifast after deducting liabilities. It represents the owners’ claim on the company’s assets and earnings.

Year-to-Year Analysis

Comparing balance sheet figures year-to-year allows investors to identify trends, growth patterns, and potential financial risks, facilitating informed investment decisions.

Interpreting the Data

Detailed analysis of assets, liabilities, and equity can provide investors with comprehensive insights into Medifast's financial standing, aiding in investment evaluations and risk assessments.

 
NET INCOME (M)
DEPRECIATION (M)
DEFERRED TAXES (M)
CHANGES IN WORKING CAPITAL (M)
NON-CASH ITEM (M)
PAID INTEREST (M)
PAID TAXES (M)
NET CASH FLOW FROM OPERATING ACTIVITIES (M)
CAPITAL EXPENDITURES (M)
CASH FLOW FROM INVESTING ACTIVITIES (M)
CASH FLOW FROM OTHER INVESTING ACTIVITIES (M)
INTEREST INCOME AND EXPENSES (M)
NET DEBT CHANGE (M)
NET CHANGE IN EQUITY (M)
CASH FLOW FROM FINANCING ACTIVITIES (M)
CASH FLOW FROM OTHER FINANCING ACTIVITIES (k)
TOTAL DIVIDENDS PAID (M)
NET CHANGE IN CASH FLOW (M)
FREE CASH FLOW (M)
SHARE-BASED COMPENSATION (M)
199419951996199719981999200020012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023
000-30-3102212534111918152413201727557710216414399
00000000001223455887875444761113
0000000001000000060000-20-210-301
00-1001000-2-1-2-11-4000113-53-460-826-872120
00000100000000145571013112961314253021
000000000000000000000000000000
0000000000023139104410124111314172456-3734
000-1-10002113586192834404225292543608414594194147
-10000000-4-5-4-1-8-8-7-5-12-14-8-11-7-2-2-3-4-10-5-34-16-6
-1-2020000-4-9-3-2-6-8-7-8-23-16-11-22-20-2-3-1-6-1-29-11-61
0-10200000-310100-3-11-2-3-11420033455-54
000000000000000000000000000000
010000002200011-10-1-1-30000000000
30001000060000000-20-2-20-33-1000-29-32-3-55-126-3
31101000290001101-20-2-23-34-11-12-17-53-82-57-125-199-79
00000000000000001,00001,00000-1,000-1,000-2,0000-14,0000-6,000-1,000-3,000
0000000000000000000000-11-15-23-35-53-63-71-73
1-100000001-1001096-225-3-111710226-486-59-166
-1.7-1.1-0.5-2.1-1.1-0.1-0.10.7-2-3.7-2.91.3-2.20-1.213.816.720.232.23118.526.622.54055.974.2139.360.3177.9141.17
000000000000000000000000000000

Medifast stock margins

The Medifast margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Medifast. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Medifast.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Medifast's sales revenue. A higher gross margin percentage indicates that the Medifast retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Medifast's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Medifast's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Medifast's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Medifast. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Medifast's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Medifast Margin History

Medifast Gross marginMedifast Profit marginMedifast EBIT marginMedifast Profit margin
2026e73.8 %-2.66 %-4.14 %
2025e73.8 %-2.46 %-2.83 %
202473.8 %3.23 %0.35 %
202372.37 %11.79 %9.27 %
202271.34 %11.56 %8.98 %
202173.89 %14.17 %10.75 %
202074.65 %15.1 %11.01 %
201975.23 %12.75 %10.91 %
201875.83 %13.79 %11.14 %
201775.53 %13.13 %9.18 %
201674.94 %9.8 %6.48 %
201573.79 %10.52 %7.37 %
201473.33 %10.59 %4.63 %
201374.24 %11.85 %7.41 %
201274.04 %8.51 %4.99 %
201175.29 %9.19 %6.2 %
201074.73 %12.27 %7.61 %
200973.31 %10.9 %6.72 %
200871.84 %6.72 %3.91 %
200774.34 %6.8 %4.06 %
200675.3 %9.99 %7.02 %
200574.81 %8.73 %5.24 %

Medifast Stock Sales Revenue, EBIT, Earnings per Share

The Medifast earnings per share therefore indicates how much revenue Medifast has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Sales per Share
EBIT per share
Earnings per Share
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Medifast earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Medifast's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Medifast’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Medifast's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Medifast Revenue, EBIT and net profit per share

DateMedifast Sales per ShareMedifast EBIT per shareMedifast Earnings per Share
2026e36.38 undefined0 undefined-1.5 undefined
2025e37.49 undefined0 undefined-1.06 undefined
202454.95 undefined1.78 undefined0.19 undefined
202398.16 undefined11.57 undefined9.1 undefined
2022141.47 undefined16.35 undefined12.71 undefined
2021129.33 undefined18.32 undefined13.9 undefined
202078.55 undefined11.87 undefined8.65 undefined
201958.98 undefined7.52 undefined6.44 undefined
201841.4 undefined5.71 undefined4.61 undefined
201724.93 undefined3.27 undefined2.29 undefined
201623.07 undefined2.26 undefined1.5 undefined
201522.55 undefined2.37 undefined1.66 undefined
201422.29 undefined2.36 undefined1.03 undefined
201323.49 undefined2.78 undefined1.74 undefined
201223.26 undefined1.98 undefined1.16 undefined
201121 undefined1.93 undefined1.3 undefined
201017.64 undefined2.16 undefined1.34 undefined
200911.54 undefined1.26 undefined0.78 undefined
20087.7 undefined0.52 undefined0.3 undefined
20076.16 undefined0.42 undefined0.25 undefined
20065.49 undefined0.55 undefined0.39 undefined
20053.13 undefined0.27 undefined0.16 undefined

Medifast business model

Medifast Inc. is a leading provider of health and wellness solutions, with its headquarters in Baltimore, Maryland. The company was founded in 1980 by Dr. William Vitale and has since experienced continuous growth. Medifast's nutrition and health products are available in the United States, Canada, and Puerto Rico. Medifast is one of the most popular companies on Eulerpool.com.

Medifast SWOT Analysis

Strengths

Medifast Inc has several strengths that contribute to its success in the market.

  • Strong brand recognition and reputation.
  • Well-established distribution network.
  • Diverse range of products and services.
  • Proven track record of customer satisfaction.
  • Effective marketing strategies.

Weaknesses

Despite its strengths, Medifast Inc also faces certain weaknesses that need to be addressed.

  • Dependency on a limited number of suppliers.
  • Relatively high pricing compared to competitors.
  • Inadequate international presence.
  • Limited product diversification within certain segments.

Opportunities

Medifast Inc has several opportunities in the market that can drive its future growth.

  • Increasing consumer awareness and demand for health-focused products.
  • Growing population of individuals seeking weight management solutions.
  • Potential partnerships with complementary businesses.
  • Expansion into untapped international markets.
  • Technological advancements enabling efficient product development and delivery.

Threats

Medifast Inc must be aware of potential threats that could impact its business negatively.

  • Intense competition from both traditional and emerging players.
  • Government regulations and policies affecting the health and wellness industry.
  • Economic downturns leading to decreased consumer spending.
  • Shifts in consumer preferences towards alternative weight management methods.
  • Negative publicity or product quality issues affecting brand perception.

LIMITED TIME OFFER

The World’s Best Investors Are On Eulerpool

Subscribe for $2

Medifast Eulerpool Fair Value

Details

Fair Value

ⓘ

Understanding Fair Value

The fair value of a stock provides insights into whether the stock is currently undervalued or overvalued. It is calculated based on profit, revenue, or dividends and offers a comprehensive perspective of the stock’s intrinsic value.

Income-Based Fair Value

This is calculated by multiplying the earnings per share by the average P/E ratio of the selected past years for smoothing. If the fair value is higher than the current market price, it suggests that the stock is undervalued.

Example 2022

Fair Value Profit 2022 = Earnings per Share 2022 / Average P/E Ratio 2019 - 2021 (3 Years Smoothing)

Revenue-Based Fair Value

It is derived by multiplying the revenue per share by the average price-to-sales ratio of the selected past years for smoothing. An undervalued stock is identified if the fair value exceeds the ongoing market price.

Example 2022

Fair Value Revenue 2022 = Revenue per Share 2022 / Average PSR 2019 - 2021 (3 Years Smoothing)

Dividend-Based Fair Value

This value is determined by dividing the dividend per share by the average dividend yield of the selected past years for smoothing. A higher fair value than the market price indicates an undervalued stock.

Example 2022

Fair Value Dividend 2022 = Dividend per Share 2022 * Average Dividend Yield 2019 - 2021 (3 Years Smoothing)

Expectations and Forecasts

Future expectations provide potential trajectories for stock prices and aid investors in decision-making. The expected values are forecasted figures of fair value, taking into account the growth or decline trends of profit, revenue, or dividend.

Comparative Analysis

Comparing the fair value based on profit, revenue, and dividend provides a holistic overview of the stock’s financial health. Observing the annual and per-annual variations contributes to understanding the consistency and reliability of stock performance.

Medifast historical P/E ratio, EBIT multiple, and P/S ratio

LIMITED TIME OFFER

The World’s Best Investors Are On Eulerpool

Subscribe for $2

Medifast shares outstanding

The number of shares was Medifast in 2024 — This indicates how many shares 10.963 M is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Number of stocks
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Medifast earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Medifast's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Medifast’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Medifast's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Medifast dividend history and estimates

In 2024, Medifast paid a dividend amounting to 0 USD. Dividend means that Medifast distributes a portion of its profits to its owners.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Dividend
Dividend (Estimate)
Details

Dividend

ⓘ

Dividend Overview

The dividend per year chart for Medifast provides a comprehensive view of the annual dividends distributed to shareholders. Analyze the trend to understand the consistency and growth in dividend payouts over the years.

Interpretation and Use

A consistent or increasing trend in dividends can indicate the company's profitability and financial health. Investors can use this data to identify Medifast’s potential for long-term investment and income generation through dividends.

Investment Strategy

Incorporate the dividend data in evaluating Medifast's overall performance. A thorough analysis, considering other financial aspects, will help in making informed investment decisions for optimal capital growth and income generation.

Medifast Dividend History

DateMedifast Dividend
2026e-0.72 undefined
2025e-0.52 undefined
20234.95 undefined
20226.56 undefined
20215.68 undefined
20204.52 undefined
20193.38 undefined
20182.19 undefined
20171.44 undefined
20161.07 undefined
20150.25 undefined

Medifast dividend payout ratio

In 2024, Medifast had a payout ratio of 46.94%. The payout ratio indicates the percentage of the company's profits that Medifast distributes as dividends.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Payout ratio
Details

Payout ratio

ⓘ

What is Yearly Payout Ratio?

The yearly payout ratio for Medifast represents the proportion of earnings paid out as dividends to shareholders. It is an indicator of the company's financial health and stability, illustrating how much profit is being returned to investors versus being reinvested back into the company.

How to Interpret the Data

A lower payout ratio for Medifast could mean that the company is reinvesting more into its growth, whereas a higher ratio indicates more earnings are being distributed as dividends. Investors seeking regular income might prefer companies with a higher payout ratio, while those looking for growth may opt for companies with a lower ratio.

Using the Data for Investments

Evaluate Medifast's payout ratio in conjunction with other financial metrics and performance indicators. A sustainable payout ratio, coupled with strong financial health, can indicate a reliable dividend payout. However, a very high ratio might suggest the company is not sufficiently reinvesting in its future growth.

Medifast Payout Ratio History

DateMedifast Payout ratio
2026e48.06 %
2025e48.96 %
202446.94 %
202348.29 %
202251.65 %
202140.89 %
202052.31 %
201952.57 %
201847.4 %
201763.16 %
201671.81 %
201515.06 %
201448.29 %
201348.29 %
201248.29 %
201148.29 %
201048.29 %
200948.29 %
200848.29 %
200748.29 %
200648.29 %
200548.29 %
LIMITED TIME OFFER

The World’s Best Investors Are On Eulerpool

Subscribe for $2
Unfortunately, there are currently no price targets and forecasts available for Medifast.

Medifast latest earnings and earnings surprises

DateEPS EstimateEPS ActualQuarterly report
12/31/2024-0.16 0.1  (161.88 %)2024 Q4
9/30/2024-0.28 0.35  (225.09 %)2024 Q3
6/30/20240.39 0.92  (133.56 %)2024 Q2
3/31/20240.79 0.66  (-16.22 %)2024 Q1
12/31/20230.97 0.55  (-43.28 %)2023 Q4
9/30/20231.08 2.12  (97.08 %)2023 Q3
6/30/20231.45 2.77  (90.46 %)2023 Q2
3/31/20232.42 3.67  (51.53 %)2023 Q1
12/31/20222.24 3.27  (45.84 %)2022 Q4
9/30/20221.93 3.27  (69.51 %)2022 Q3
1
2
3
4
5
...
9

Eulerpool ESG Scorecard© for the Medifast stock

Eulerpool World ESG Rating (EESG©)

38/ 100

🌱 Environment

8

👫 Social

39

🏛️ Governance

68

Environment

Scope 1 - Direct Emissions
Scope 2 - Indirect emissions from purchased energy
Scope 3 - Indirect emissions within the value chain
Total CO₂ emissions
CO₂ reduction strategy
Coal energy
Nuclear power
Animal experiments
Fur & Leather
Pesticides
Palm Oil
Tobacco
Genetically modified organisms
Climate concept
Sustainable forestry
Recycling regulations
Environmentally friendly packaging
Hazardous substances
Fuel consumption and efficiency
Water consumption and efficiency

Social

Percentage of female employees49
Percentage of women in management
Percentage of Asian employees
Share of Asian management
Percentage of Hispanic/Latino employees
Hispano/Latino Management share
Percentage of Black employees
Black Management Share
Percentage of white employees
White Management Share
Adult content
Alcohol
Weapons
Firearms
Gambling
Military contracts
Human rights concept
Privacy concept
Occupational health and safety
Catholic

Governance (Corporate Governance)

Environmental reporting
Stakeholder Engagement
Call Back Policies
Antitrust law

The Eulerpool ESG Scorecard© is the strictly copyrighted intellectual property of Eulerpool Research Systems. Any unauthorized use, imitation, or infringement will be actively pursued and may lead to significant legal consequences. For licenses, collaborations, or usage rights, please contact us directly via our contact form. Contact Form to us.

Medifast shareholders

%
Name
Stocks
Change
Date
8.26082 % Renaissance Technologies LLC903,734-102,47612/31/2024
7.69386 % BlackRock Institutional Trust Company, N.A.841,70843,45112/31/2024
6.83380 % The Vanguard Group, Inc.747,61827,21712/31/2024
4.09569 % Two Sigma Investments, LP448,069123,72212/31/2024
2.69543 % Hotchkis and Wiley Capital Management, LLC294,880012/31/2024
2.63970 % D. E. Shaw & Co., L.P.288,78380,00012/31/2024
2.54303 % Federated MDTA LLC278,20861,72312/31/2024
2.52353 % BofA Global Research (US)276,074-38,65412/31/2024
2.49188 % Acadian Asset Management LLC272,612-12,23612/31/2024
2.39452 % Goldman Sachs Asset Management, L.P.261,96110,73612/31/2024
1
2
3
4
5
...
10

Medifast Executives and Management Board

Mr. Daniel Chard

(58)
Medifast Chairman of the Board, Chief Executive Officer (since 2016)
Compensation 7.04 M

Mr. James Maloney

(56)
Medifast Chief Financial Officer
Compensation 2.01 M

Mr. Nicholas Johnson

(44)
Medifast Chief Field Operations Officer
Compensation 1.7 M

Mr. Jason Groves

(53)
Medifast Executive Vice President, General Counsel, Corporate Secretary (since 2009)
Compensation 1.63 M

Mr. Anthony Tyree

(59)
Medifast Chief Marketing Officer, Chief Business Operations
Compensation 1.63 M
1
2
3

Most common questions regarding Medifast

What values and corporate philosophy does Medifast represent?

Medifast Inc represents a strong commitment to health and wellness through its values and corporate philosophy. With a focus on scientific research and evidence-based nutrition, the company offers effective weight loss and management solutions. Medifast prioritizes customer satisfaction, transparency, and integrity, making it a trusted name in the industry. By providing personalized support and a comprehensive approach to well-being, Medifast empowers individuals to achieve their health goals. With its dedication to high-quality products and services, Medifast Inc continues to lead the way in transformative wellness solutions.

In which countries and regions is Medifast primarily present?

Medifast Inc is primarily present in the United States, Canada, and certain selected international markets.

What significant milestones has the company Medifast achieved?

Medifast Inc has achieved several significant milestones throughout its history. Some notable achievements include expanding their product lineup to offer a wide range of weight management and nutrition products. The company has also witnessed rapid growth and increased market presence, becoming a leading provider of healthy living products and programs. Medifast Inc has received numerous industry accolades and recognition for their innovative approach to healthy living, including being named as one of Forbes' "100 Most Trustworthy Companies" and earning the Good Housekeeping Seal of Approval. Additionally, Medifast Inc has successfully established a strong network of independent OPTAVIA coaches, empowering individuals to achieve optimal health and financial well-being.

What is the history and background of the company Medifast?

Medifast Inc, a leading provider of health and wellness products, has a rich history and background. Established in 1980, Medifast has been dedicated to helping people achieve their weight loss and healthy lifestyle goals. With over four decades of experience, the company has developed science-based programs that combine proper nutrition, support, and education to deliver effective and sustainable results. Medifast's commitment to innovation and quality has earned them a strong reputation in the industry. By offering a wide range of nutritional products and personalized support, Medifast continues to empower individuals on their journey towards better health and wellbeing.

Who are the main competitors of Medifast in the market?

Medifast Inc faces competition from various companies operating in the health and wellness industry. Some of the main competitors of Medifast Inc include Weight Watchers International Inc, Nutrisystem Inc, Herbalife Nutrition Ltd, and WW International Inc. These companies offer similar products and services aimed at promoting healthy living, weight management, and overall wellbeing. Medifast Inc strives to differentiate itself from its competitors through innovative products, personalized customer support, and a strong focus on scientific research and development. Through continuous efforts, Medifast Inc aims to maintain its position and popularity among consumers in the competitive market.

In which industries is Medifast primarily active?

Medifast Inc is primarily active in the nutrition and weight management industry.

What is the business model of Medifast?

Medifast Inc. operates under a direct selling business model, providing weight management and health products. This company offers various weight loss programs, including their popular Optavia brand. Medifast sells its products through a network of independent distributors and coaches, who assist individuals in achieving their health and wellness goals. By emphasizing the importance of nutrition, portion control, and regular exercise, Medifast aims to help customers maintain a healthier lifestyle. With its extensive product line and dedicated network of distributors, Medifast Inc. remains committed to assisting individuals in achieving sustainable weight loss and overall well-being.

What is the P/E ratio of Medifast 2025?

The Medifast P/E ratio is -11.52.

What is the P/S ratio of Medifast 2025?

The Medifast P/S ratio is 0.33.

What is the Quality Investing of Medifast?

The Quality Investing for Medifast is 3/10.

What is the revenue of Medifast 2025?

The expected Medifast revenue is 410.16 M USD.

How high is the profit of Medifast 2025?

The expected Medifast profit is -11.6 M USD.

What is the business model of Medifast

Medifast Inc is a leading American company in the health and nutrition industry. The company's business model is based on the production and sale of dietary supplements, meal replacement shakes, snacks, and other products for weight loss and healthy nutrition. Medifast Inc also offers training programs and support for people who want to control their weight and implement a healthy diet. An important part of Medifast Inc's business model is the OPTAVIA® brand. OPTAVIA® is an innovative concept that provides comprehensive support for nutrition and weight loss. The program includes personalized nutritional counseling, access to online tools and resources, and support from a coach. The OPTAVIA® brand is one of Medifast Inc's main sources of revenue and has contributed to the company's growth and expansion. Medifast Inc also offers other brands such as Medifast®, Thrive by Medifast™, and Jason Pharmaceuticals™. Medifast® offers meal replacement shakes, bars, and soups that are intended to promote effective weight loss. Thrive by Medifast™ is a brand based on the principle that a healthy diet is the best foundation for optimal physical and mental health. Jason Pharmaceuticals™ is a brand specializing in the development and marketing of products that support women in various stages of their lives (such as pregnancy, menopause, etc.). Medifast Inc distributes its products and services through various channels such as direct sales, online orders, and distribution partners. The company has an extensive network of over 30,000 independent distribution partners who serve as OPTAVIA® coaches. These coaches are trained nutrition experts who provide their clients with personalized nutrition plans and support in achieving their weight loss goals. Medifast Inc's business model is based on a holistic approach to healthy eating and weight loss. The company is committed to offering high-quality products based on scientific knowledge and providing its customers with comprehensive support in implementing a healthy lifestyle. Medifast Inc has built a strong market position through its commitment to quality and customer satisfaction and is a leading provider of dietary supplements and meal replacement products in the US and the world. Overall, Medifast Inc's business model is focused on high-quality products, personalized support, and a wide range of offerings for customers. Medifast Inc has become an important company in the health and nutrition industry and is dedicated to providing its customers with high-quality and comprehensive support in implementing a healthy lifestyle.

What is the Medifast dividend?

Medifast pays a dividend of 6.56 USD distributed over 4 payouts per year.

How often does Medifast pay dividends?

Medifast pays out a dividend 4 times a year.

What is the Medifast ISIN?

The ISIN of Medifast is US58470H1014.

What is the Medifast WKN?

The WKN of Medifast is 889384.

What is the Medifast ticker?

The ticker of Medifast is MED.

How much dividend does Medifast pay?

Over the past 12 months, Medifast paid a dividend of 4.95 USD . This corresponds to a dividend yield of about 40.59 %. For the coming 12 months, Medifast is expected to pay a dividend of -0.72 USD.

What is the dividend yield of Medifast?

The current dividend yield of Medifast is 40.59 %.

When does Medifast pay dividends?

Medifast pays a quarterly dividend. This is distributed in the months of January, April, July, October.

How secure is the dividend of Medifast?

Medifast paid dividends every year for the past 0 years.

What is the dividend of Medifast?

For the upcoming 12 months, dividends amounting to -0.72 USD are expected. This corresponds to a dividend yield of -5.93 %.

In which sector is Medifast located?

Medifast is assigned to the 'Non-cyclical consumption' sector.

Wann musste ich die Aktien von Medifast kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Medifast from 11/7/2023 amounting to 1.65 USD, you needed to have the stock in your portfolio before the ex-date on 9/18/2023.

When did Medifast pay the last dividend?

The last dividend was paid out on 11/7/2023.

What was the dividend of Medifast in the year 2024?

In the year 2024, Medifast distributed 4.95 USD as dividends.

In which currency does Medifast pay out the dividend?

The dividends of Medifast are distributed in USD.

All fundamentals about Medifast

Our stock analysis for Medifast Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Medifast Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.